Literature DB >> 31621921

Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.

Johan O Paulsson1, Samuel Backman2, Na Wang1, Adam Stenman1,3,4, Joakim Crona5, Jessada Thutkawkorapin3,6, Mehran Ghaderi1, Emma Tham3,6, Peter Stålberg2, Jan Zedenius3,4, C Christofer Juhlin1,7.   

Abstract

The genetics underlying thyroid cancer dedifferentiation is only partly understood and has not yet been characterised using comprehensive pan-genomic analyses. We investigated a unique case with synchronous follicular thyroid carcinoma (FTC), poorly differentiated thyroid carcinoma (PDTC), and anaplastic thyroid carcinoma (ATC), as well as regional lymph node metastases from the PDTC and ATC from a single patient using whole-genome sequencing (WGS). The FTC displayed mutations in CALR, RB1, and MSH2, and the PDTC exhibited mutations in TP53, DROSHA, APC, TERT, and additional DNA repair genes - associated with an immense increase in sub-clonal somatic mutations. All components displayed an overrepresentation of C>T transitions with associated microsatellite instability (MSI) in the PDTC and ATC, with borderline MSI in the FTC. Clonality analyses pinpointed a shared ancestral clone enriched for mutations in TP53-associated regulation of DNA repair and identified important sub-clones for each tumour component already present in the corresponding preceding lesion. This genomic characterisation of the natural progression of thyroid cancer reveals several novel genes of interest for future studies. Moreover, the findings support the theory of a stepwise dedifferentiation process and suggest that defects in DNA repair could play an important role in the clonal evolution of thyroid cancer.
© 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  DNA repair; clonality; dedifferentiation; thyroid carcinoma; whole-genome sequencing

Year:  2019        PMID: 31621921     DOI: 10.1002/path.5359

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.

Authors:  Adam Stenman; L Samuel Hellgren; Kenbugul Jatta; Martin Hysek; Maja Zemmler; Renske Altena; Inga-Lena Nilsson; Robert Bränström; Jan Zedenius; C Christofer Juhlin
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

2.  Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics.

Authors:  Jae-Hui Kim; Ji Yun Jeong; An Na Seo; Nora Jee-Young Park; Moonsik Kim; Ji Young Park
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 3.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

4.  Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data.

Authors:  Tam N M Ngo; Trang T B Le; Thoa Le; Andrey Bychkov; Naoki Oishi; Chan Kwon Jung; Lewis Hassell; Kennichi Kakudo; Huy Gia Vuong
Journal:  Endocr Pathol       Date:  2021-09-24       Impact factor: 3.943

Review 5.  ErbB inhibitors as neoadjuvant therapy for triple-positive breast cancer: a network meta-analysis.

Authors:  Danxiang Chen; Lingli Jin; Yiying Xu; Adheesh Bhandari; Ouchen Wang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 6.  Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?

Authors:  Marco Volante; Alfred K Lam; Mauro Papotti; Giovanni Tallini
Journal:  Endocr Pathol       Date:  2021-02-04       Impact factor: 3.943

Review 7.  The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.

Authors:  Amandeep Singh; Jeehoon Ham; Joseph William Po; Navin Niles; Tara Roberts; Cheok Soon Lee
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

8.  Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis.

Authors:  Han Luo; Xue Liao; Yun Qin; Qianqian Hou; Zhinan Xue; Yang Liu; Feiyang Shen; Yuelan Wang; Yong Jiang; Linlin Song; Haining Chen; Lingyun Zhang; Tao Wei; Lunzhi Dai; Li Yang; Wei Zhang; Zhihui Li; Heng Xu; Jingqiang Zhu; Yang Shu
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

Review 9.  Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers.

Authors:  Seong Keun Yoo; Young Shin Song; Young Joo Park; Jeong Sun Seo
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03

10.  Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.

Authors:  Liqi Li; Mingjie Zhu; Hu Huang; Junqiang Wu; Dong Meng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.